• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Access Selection for Chronic Total Occlusion Percutaneous Coronary Intervention and Complication Management.

作者信息

Ybarra Luiz F, Rinfret Stéphane

机构信息

London Health Sciences Centre, Schulich School of Medicine & Dentistry, Western University, 339 Windermere Road, Room B6-127, London, Ontario N6A 5A5, Canada. Electronic address: https://twitter.com/YbarraLuiz.

Division of Cardiology, Department of Medicine, McGill University, McGill University Health Centre, Glen Site, 1001 Boulevard Décarie, Montreal, Quebec H4A 3J1, Canada.

出版信息

Interv Cardiol Clin. 2021 Jan;10(1):109-120. doi: 10.1016/j.iccl.2020.09.009.

DOI:10.1016/j.iccl.2020.09.009
PMID:33223100
Abstract

Dual access for chronic total occlusion percutaneous coronary intervention is considered best practice by many experts. There are 2 access sites: radial and femoral. Both accesses have important advantages and disadvantages. Determining the ratio risk/benefit-efficacy/safety of each access for each patient in a specific procedure should be based on procedural and clinical variables. Given the safety benefit and the minimal procedural disadvantages, radial access should be the standard approach, especially in procedures of low complexity and in patients at high risk of vascular complications. Nonetheless, mastering both approaches is important because they are needed in multiple occasions.

摘要

相似文献

1
Access Selection for Chronic Total Occlusion Percutaneous Coronary Intervention and Complication Management.
Interv Cardiol Clin. 2021 Jan;10(1):109-120. doi: 10.1016/j.iccl.2020.09.009.
2
Procedural Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions Via the Radial Approach: Insights From an International Chronic Total Occlusion Registry.经桡动脉入路行慢性完全闭塞病变经皮冠状动脉介入治疗的操作结果:来自国际慢性完全闭塞病变注册研究的见解。
JACC Cardiovasc Interv. 2019 Feb 25;12(4):346-358. doi: 10.1016/j.jcin.2018.11.019.
3
Access for percutaneous coronary intervention in ST segment elevation myocardial infarction: radial vs. femoral--a prospective, randomised clinical trial (OCEAN RACE).ST段抬高型心肌梗死经皮冠状动脉介入治疗的入路:桡动脉与股动脉——一项前瞻性随机临床试验(OCEAN RACE)
Kardiol Pol. 2014;72(7):604-11. doi: 10.5603/KP.a2014.0071. Epub 2014 Mar 27.
4
Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007-2012).经皮冠状动脉介入治疗中桡动脉入路的采用和与股动脉入路的结果比较:国家心血管数据登记处(2007-2012 年)的最新报告。
Circulation. 2013 Jun 11;127(23):2295-306. doi: 10.1161/CIRCULATIONAHA.112.000536.
5
Comparison of radial, brachial, and femoral accesses using hemostatic devices for percutaneous coronary intervention.使用止血装置进行经皮冠状动脉介入治疗时桡动脉、肱动脉和股动脉入路的比较。
Cardiovasc Interv Ther. 2018 Jan;33(1):62-69. doi: 10.1007/s12928-016-0439-4. Epub 2016 Nov 9.
6
Radial Versus Femoral Access in Chronic Total Occlusion Percutaneous Coronary Intervention.经皮冠状动脉介入治疗中慢性完全闭塞病变经桡动脉与股动脉入路的比较。
Circ Cardiovasc Interv. 2019 Jun;12(6):e007778. doi: 10.1161/CIRCINTERVENTIONS.118.007778. Epub 2019 Jun 14.
7
Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women).将一项随机临床试验嵌入到现有的注册研究基础设施中:通过 Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women) 研究设计提高效率的独特机会。
Am Heart J. 2013 Sep;166(3):421-8. doi: 10.1016/j.ahj.2013.06.013. Epub 2013 Jul 23.
8
Vascular Closure Devices Attenuate Femoral Access Complications of Primary Percutaneous Coronary Intervention.血管闭合装置可减少经皮冠状动脉介入治疗的股动脉入路并发症。
J Invasive Cardiol. 2020 Oct;32(10):364-370. doi: 10.25270/jic/20.00105.
9
Radial Versus Femoral Approach for Percutaneous Coronary Intervention: MACE Outcomes at Long-Term Follow-up.经皮冠状动脉介入治疗的桡动脉与股动脉入路:长期随访的主要不良心血管事件结局
J Invasive Cardiol. 2018 Jul;30(7):262-268.
10
Safety of coronary angiography and percutaneous coronary intervention via the radial versus femoral route in patients on uninterrupted oral anticoagulation with warfarin.在接受华法林持续口服抗凝治疗的患者中,经桡动脉与股动脉途径进行冠状动脉造影和经皮冠状动脉介入治疗的安全性。
Am Heart J. 2014 Oct;168(4):537-44. doi: 10.1016/j.ahj.2014.06.016. Epub 2014 Jul 3.

引用本文的文献

1
Transradial and Transfemoral Access for Retrograde Chronic Total Occlusion Percutaneous Coronary Interventions: A Comparison of the Clinical Features and Prognostic Implications.经桡动脉和经股动脉途径用于逆向慢性完全闭塞性经皮冠状动脉介入治疗:临床特征与预后意义的比较
Int J Gen Med. 2024 Aug 26;17:3689-3698. doi: 10.2147/IJGM.S479408. eCollection 2024.
2
Access Site Selection and Outcomes for Chronic Total Occlusion Percutaneous Coronary Interventions: Insights from the VA CART Program.慢性完全闭塞性经皮冠状动脉介入治疗的穿刺部位选择与预后:来自退伍军人事务部CART项目的见解
J Soc Cardiovasc Angiogr Interv. 2022 Aug 24;1(6):100440. doi: 10.1016/j.jscai.2022.100440. eCollection 2022 Nov-Dec.
3
Establishment of a Risk Scoring Model for Perioperative Unex-Plained Shock during Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion.
用于慢性完全闭塞性病变经皮冠状动脉介入治疗围手术期不明原因休克的风险评分模型的建立
Rev Cardiovasc Med. 2022 Oct 11;23(10):342. doi: 10.31083/j.rcm2310342. eCollection 2022 Oct.
4
Rosuvastatin plus ticagrelor decreases the risk of major adverse cardiovascular events and elevates cardiac function compared with ticagrelor alone in patients undergoing percutaneous coronary intervention: A meta‑analysis.与单独使用替格瑞洛相比,瑞舒伐他汀联合替格瑞洛可降低接受经皮冠状动脉介入治疗患者的主要不良心血管事件风险并改善心功能:一项荟萃分析。
Exp Ther Med. 2023 Sep 25;26(5):525. doi: 10.3892/etm.2023.12224. eCollection 2023 Nov.